ALOT vs NVDA

ALOT's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and profitability health. The absence of an Altman Z-Score and Graham Number removes critical safety checks, while negative profit margins and declining revenue growth signal deteriorating fundamentals. Despite strong earnings growth (65.1% YoY) and recent EPS surprises, the company's negative ROE (-19.92%) and declining revenue (-3.10% YoY) undermine sustainability. The stock trades at a discount to book value (P/B: 0.86) but lacks intrinsic value support, suggesting the market prices in speculative recovery expectations.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.